Pre-Clinical Development of MUC1 and ErbB Dual-Targeting Chimeric Antigen Receptor (CAR) Immunotherapy for Malignant Pleural Mesothelioma (MPM)

Project: Research

Project Details

StatusFinished
Effective start/end date1/10/201430/09/2018